**Core Concept**
Methotrexate is a chemotherapeutic agent used to treat various cancers and autoimmune diseases. Its efficacy and safety can be influenced by its pharmacokinetics, particularly its ionization state in the body. As a weak acid, methotrexate's ionization status affects its renal excretion and distribution.

**Why the Correct Answer is Right**
Methotrexate's weak acid nature means it exists in equilibrium between its ionized and non-ionized forms in the body. At a high urinary pH, more methotrexate is ionized, reducing its reabsorption in the renal tubules. This increases its excretion in the urine, which is beneficial during treatment as it helps to prevent toxicity. The ionized form of methotrexate is also less likely to cross cell membranes and interact with its target enzymes, further reducing its toxicity.

**Why Each Wrong Option is Incorrect**
**Option A:** Bladder irritation is not directly related to the ionization state of methotrexate. While high urinary pH may reduce irritation, this is not the primary reason for maintaining a high pH during methotrexate treatment.
**Option B:** Methotrexate's renal tubular secretion is not decreased by high urinary pH. Instead, high pH increases its excretion by reducing reabsorption in the renal tubules.
**Option C:** Leucovorin toxicity is not increased in a dehydrated patient due to high urinary pH. Leucovorin is used to counteract methotrexate toxicity, and its toxicity is not directly related to urinary pH.

**Clinical Pearl / High-Yield Fact**
When administering methotrexate, it is essential to maintain adequate hydration and urinary alkalinization to enhance its excretion and reduce the risk of toxicity. This can be achieved by administering citrate or bicarbonate to raise the urinary pH.

**✓ Correct Answer: D. Methotrexate is a weak acid**